ATE271042T1 - Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren - Google Patents

Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren

Info

Publication number
ATE271042T1
ATE271042T1 AT01902578T AT01902578T ATE271042T1 AT E271042 T1 ATE271042 T1 AT E271042T1 AT 01902578 T AT01902578 T AT 01902578T AT 01902578 T AT01902578 T AT 01902578T AT E271042 T1 ATE271042 T1 AT E271042T1
Authority
AT
Austria
Prior art keywords
pets
pyrimidine
farm animals
endothelin antagonists
endothelin
Prior art date
Application number
AT01902578T
Other languages
English (en)
Inventor
Bernard J Banks
Adrian P Foster
Stephen P Gibson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE271042T1 publication Critical patent/ATE271042T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
AT01902578T 2000-02-11 2001-02-06 Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren ATE271042T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0003234.2A GB0003234D0 (en) 2000-02-11 2000-02-11 Method of treatment
PCT/IB2001/000142 WO2001058882A1 (en) 2000-02-11 2001-02-06 Use of pyrimidine endothelin antagonists in companion animals

Publications (1)

Publication Number Publication Date
ATE271042T1 true ATE271042T1 (de) 2004-07-15

Family

ID=9885465

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01902578T ATE271042T1 (de) 2000-02-11 2001-02-06 Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren

Country Status (17)

Country Link
EP (1) EP1254120B1 (de)
JP (1) JP2003528050A (de)
KR (1) KR20020075791A (de)
AT (1) ATE271042T1 (de)
AU (1) AU3043601A (de)
CA (1) CA2398007A1 (de)
DE (1) DE60104283T2 (de)
DK (1) DK1254120T3 (de)
ES (1) ES2222975T3 (de)
GB (1) GB0003234D0 (de)
HU (1) HUP0204370A3 (de)
IL (1) IL150488A0 (de)
NZ (1) NZ519002A (de)
PT (1) PT1254120E (de)
TR (1) TR200401815T4 (de)
WO (1) WO2001058882A1 (de)
ZA (1) ZA200206343B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
AU2006236345B2 (en) * 2005-04-19 2011-03-31 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of kidney disease
CN102770195B (zh) * 2010-02-25 2015-03-04 弗·哈夫曼-拉罗切有限公司 高亲和性化合物结合常数的测定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100456650B1 (ko) * 1995-12-20 2005-06-20 야마노우치세이야쿠 가부시키가이샤 아릴에텐설폰아미드유도체
WO1998057938A1 (en) * 1997-06-19 1998-12-23 Yamanouchi Pharmaceutical Co., Ltd. Substituted lower alkanesulfonamide derivatives and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
AU3043601A (en) 2001-08-20
EP1254120B1 (de) 2004-07-14
DE60104283D1 (de) 2004-08-19
KR20020075791A (ko) 2002-10-05
WO2001058882A1 (en) 2001-08-16
EP1254120A1 (de) 2002-11-06
HUP0204370A2 (en) 2003-05-28
DK1254120T3 (da) 2004-10-04
IL150488A0 (en) 2002-12-01
TR200401815T4 (tr) 2004-08-23
NZ519002A (en) 2004-06-25
JP2003528050A (ja) 2003-09-24
ZA200206343B (en) 2003-08-08
PT1254120E (pt) 2004-10-29
HUP0204370A3 (en) 2003-07-28
CA2398007A1 (en) 2001-08-16
DE60104283T2 (de) 2004-11-18
GB0003234D0 (en) 2000-04-05
ES2222975T3 (es) 2005-02-16

Similar Documents

Publication Publication Date Title
ATE439762T1 (de) Verwaltungssystem von lebendem inventar und verfahren zur trenngewichtfütterung
PT1176875E (pt) Utilizacao da cretina como aditivo de forragens
DK1460893T3 (da) Strøelse til dyr
ITMO910147A0 (it) Tavolo per asciugatura e toellettatura cani, gatti e altri animali domestici.
DE59208113D1 (de) Säureanilid-Derivate und ihre Verwendung zur Bekämpfung von Botrytis
MX261332B (es) Uso de proteasas estables en acido para alimento de animales.
TR200401584T4 (tr) Bir kontrollü salımlı matris içeren, hayvan besininde kullanım için bileşim, bu bileşimin hazırlanması için işlem ve bu bileşimin kullanımı
NO964912D0 (no) Tyggbare flubendazoltabletter for selskapsdyr
DE3784663D1 (de) Pflegemittel, insbesondere zur pflege des gebisses von hunden.
ATE336177T1 (de) Hypoallergene diätetische zusammensetzung für haustiere.
UA87297C2 (ru) Противопаразитарный кормовой премикс для животных и способ его получения
Abensperg-Traun A study of home range, movements and shelter use in adult and juvenile echidnas, Tachyglossus aculeatus (Monotremata: Tachyglossidae), in Western Australian wheatbelt reserves.
BRPI0413025A (pt) compostos orgánicos
DE60104283D1 (de) Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren
RU2001117033A (ru) Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
ATE77237T1 (de) Anthelmintische acylhydrazone, verfahren zur verwendung und zusammensetzungen.
ATE245604T1 (de) Verwendung von porphyrinderivaten in aquarien
ATE31306T1 (de) Chinazolinon-derivate wirksam gegen coccidiosis.
ATE71839T1 (de) Anthelmintische acylhydrazone verfahren zur verwendung und zusammensetzungen.
ATA104691A (de) Streu fuer die tierhaltung
Pain My pet possum
KR20200008202A (ko) 반려견 교배 어플
ATE451120T1 (de) Verwendung von ziegenserum zur veterinärmedizinischen behandlung
SV2004001611A (es) Uso especial o no evidente de la 2 undecanona como aditivo en la elaboracion de bolsas plasticas y masterbatch para lograr repeler animales como perros y gatos
BG101048A (en) Shampoo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1254120

Country of ref document: EP

REN Ceased due to non-payment of the annual fee